Organization
Ceregene, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Ceregene, Inc.
... the treatment of Alzheimer's disease (AD). This novel product was developed by Ceregene, Inc., which was recently acquired by Sangamo. The datawere presented at the ...
... treated subjects in cohorts 1-3 of the SB-728-902 study. * Acquisition of Ceregene, Inc. On October 1, Sangamo completed the acquisition of Ceregene, Inc., a ...
... Idec Inc. BrainStorm Cell Therapeutics Inc. California Stem Cell, Inc. Cellceutix Corporation Ceregene, Inc. Cytokinetics, Inc D-Pharm Ltd. Daval International Ltd. Eisai Co., Ltd. Genzyme ...
... into an Agreement and Plan of Merger (the "Merger Agreement") with Ceregene, Inc., ("Ceregene") and a stockholders' representative. Pursuant to the Merger Agreement, the Company ...
... Sangamo BioSciences to Acquire Ceregene . Sangamo BioSciences to Acquire Ceregene. Acquisition Provides Significant Portfolio of AAV Assets IncludingManufacturing, Regulatory and Intellectual Property ...
... The report profiles 35 companies including Alnylam Pharmaceuticals, Inc., AmpliPhi Biosciences Corp., Ceregene, Inc., Cortex Pharmaceuticals, Inc., Intellect Neurosciences Incorporation, Prana Biotechnology Limited, Raptor Pharmaceuticals ...
... Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study . Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study Ceregene, Inc. ...
... Ceregene Reports Data From Parkinson's Disease Phase 2b Study . Ceregene Reports Data From Parkinson's Disease Phase 2b Study Ceregene, Inc. today announced ...
... Ceregene Reports Data From Parkinson's Disease Phase 2b Study . Ceregene, Inc. today announced the top-line data from its double-blind, randomized, controlled Phase ...
... Disease Cooperative Study Group Complete Enrollment Of CERE-110 Phase 2 Trial . Ceregene And Alzheimer's Disease Cooperative Study Group Complete Enrollment Of CERE-110 Phase 2 ...
Subscribe now for full coverage on Ceregene, Inc.
Start My Free Trial